FORM OF AMENDMENT NO. 12 to the FEE WAIVER AND EXPENSE PAYMENT REIMBURSEMENT AGREEMENTPayment Reimbursement Agreement • April 17th, 2013 • Munder Series Trust
This Amendment is made as of , 2013 to the Fee Waiver and Expense Payment Reimbursement Agreement dated August 14, 2007 (“Agreement”), as amended, between Munder Series Trust (“MST”) and Munder Capital Management (“MCM”).
AMENDMENT NO. 13 to the FEE WAIVER AND EXPENSE PAYMENT REIMBURSEMENT AGREEMENTPayment Reimbursement Agreement • October 28th, 2013 • Munder Series Trust
This Amendment is made as of September 6, 2013 to the Fee Waiver and Expense Payment Reimbursement Agreement dated August 14, 2007 (“Agreement”), as amended, between Munder Series Trust (“MST”) and Munder Capital Management (“MCM”).
PAYMENT REIMBURSEMENT AGREEMENTPayment Reimbursement Agreement • June 25th, 2014 • rEVO Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS PAYMENT REIMBURSEMENT AGREEMENT (this “Agreement”) is effective as of March 31, 2014 (the “Effective Date”), by and between rEVO Biologics, Inc., a Delaware corporation, having its principal place of business located at 175 Crossing Boulevard, Framingham, Massachusetts, 01702 (“rEVO”), and LFB USA, Inc., a Delaware corporation, having its principal place of business located at 175 Crossing Boulevard, Framingham, Massachusetts, 01702 (“LFB USA”). Each of rEVO and LFB USA may be referred to herein as a “Party” or collectively as the “Parties.”
